A public health task force is evaluating the performance of various diagnostic and screening tests across different clinical settings. They must anticipate how altering diagnostic thresholds or changing the tested population will impact the statistical characteristics of the tests. Match each clinical scenario with the most accurate description of its impact on the test's performance metrics.
- Lowering the serum troponin cutoff level required to diagnose an acute myocardial infarctionIncreases test sensitivity and increases the false-positive rate
- Raising the fasting blood glucose threshold required for a definitive diagnosis of diabetes mellitusIncreases test specificity and increases the false-negative rate
- Implementing a screening program in a general university clinic instead of a specialized high-risk infectious disease clinicDecreases the positive predictive value and increases the negative predictive value
- Deploying a rapid respiratory antigen test during the peak of winter outbreak season instead of the summer off-seasonIncreases the positive predictive value and decreases the negative predictive value
Cevap
Properly align the clinical scenarios reflecting changes in threshold cutoffs and population disease prevalence with their downstream epidemiological effects on sensitivity, specificity, and predictive values.
Changes in test cutoffs directly alter the intrinsic balance of sensitivity and specificity by shifting the numerical boundary between positive and negative results. In contrast, changing the tested population alters the pre-test probability (prevalence), which only affects the predictive values (PPV and NPV) without changing the intrinsic test parameters.
Adım Adım Çözüm
Anahtar Kavram
Impact of diagnostic thresholds and disease prevalence on test performance characteristics